Literature DB >> 19105877

Prevalence of latent tuberculosis infection among gold miners in South Africa.

Y Hanifa1, A D Grant, J Lewis, E L Corbett, K Fielding, G Churchyard.   

Abstract

SETTING: South African gold mines.
OBJECTIVE: To determine the prevalence of latent tuberculosis infection (LTBI) and risk factors for a positive tuberculin skin test (TST) among gold miners.
DESIGN: Cross-sectional survey. Human immunodeficiency virus (HIV) status was determined by self-report and medical records. TST positivity was defined by the mirror method to estimate the prevalence of LTBI, and by the US Centers for Disease Control and Prevention definitions to explore risk factors at the individual level.
RESULTS: Among 429 participants (105/130 subjects aged <30 years, 324/390 > or = 30 years), the estimated prevalence of LTBI was 89%; 45.5% of HIV-positive participants had a zero TST response compared to respectively 13% and 13.5% in the HIV-negative and status unknown participants. In participants with TST > 0, there was no significant difference between size of response by HIV status: the mean (standard deviation) widths for HIV-positive, HIV-negative and HIV status unknown were respectively 11.84 (2.75), 12.03 (2.75) and 12.52 mm (3.04) (analysis of variance P = 0.28). Factors independently associated with a TST < 10 mm were positive HIV status (aOR 0.41, 95%CI 0.17-0.96) and not working underground (aOR 0.25, 95%CI 0.09-0.71).
CONCLUSIONS: The prevalence of LTBI is very high in gold miners in South Africa. HIV-infected individuals are more likely to have a negative TST, but HIV infection does not affect the size of TST response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19105877

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  36 in total

1.  HIV-1 and the immune response to TB.

Authors:  Naomi F Walker; Graeme Meintjes; Robert J Wilkinson
Journal:  Future Virol       Date:  2013-01       Impact factor: 1.831

Review 2.  Transforming the fight against tuberculosis: targeting catalysts of transmission.

Authors:  David W Dowdy; Andrew S Azman; Emily A Kendall; Barun Mathema
Journal:  Clin Infect Dis       Date:  2014-06-30       Impact factor: 9.079

3.  A model of tuberculosis transmission and intervention strategies in an urban residential area.

Authors:  Elsje Pienaar; Aaron M Fluitt; Scott E Whitney; Alison G Freifeld; Hendrik J Viljoen
Journal:  Comput Biol Chem       Date:  2010-03-09       Impact factor: 2.877

Review 4.  Epidemiology of tuberculosis and HIV: recent advances in understanding and responses.

Authors:  Neil A Martinson; Christopher J Hoffmann; Richard E Chaisson
Journal:  Proc Am Thorac Soc       Date:  2011-06

Review 5.  Purified protein derivatives of tuberculin--past, present, and future.

Authors:  Hongliang Yang; Nicole A Kruh-Garcia; Karen M Dobos
Journal:  FEMS Immunol Med Microbiol       Date:  2012-08-01

Review 6.  Diagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas.

Authors:  Victoria O Kasprowicz; Gavin Churchyard; Stephen D Lawn; S Bertel Squire; Ajit Lalvani
Journal:  J Infect Dis       Date:  2011-11-15       Impact factor: 5.226

Review 7.  Epidemiology of HIV-associated tuberculosis.

Authors:  Stephen D Lawn; Gavin Churchyard
Journal:  Curr Opin HIV AIDS       Date:  2009-07       Impact factor: 4.283

8.  Genomics of human pulmonary tuberculosis: from genes to pathways.

Authors:  Catherine M Stein; Lindsay Sausville; Christian Wejse; Rafal S Sobota; Nicola M Zetola; Philip C Hill; W Henry Boom; William K Scott; Giorgio Sirugo; Scott M Williams
Journal:  Curr Genet Med Rep       Date:  2017-10-12

Review 9.  The knowns and unknowns of latent Mycobacterium tuberculosis infection.

Authors:  W Henry Boom; Ulrich E Schaible; Jacqueline M Achkar
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

10.  Prospective monitoring reveals dynamic levels of T cell immunity to Mycobacterium tuberculosis in HIV infected individuals.

Authors:  Jessica E Mitchell; Shivan Chetty; Pamla Govender; Mona Pillay; Manjeetha Jaggernath; Anne Kasmar; Thumbi Ndung'u; Paul Klenerman; Bruce D Walker; Victoria O Kasprowicz
Journal:  PLoS One       Date:  2012-06-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.